Please login to read the full article.
Scrip Regulatory Affairs
Indian govt to increase scrutiny of how drug patents are "worked" domestically
19 April 2011
Anju Ghangurde
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- India grants country's first ever compulsory licence - for Bayer's Nexavar
- Higher US generic drugs user fee for foreign units 'discriminatory, anti-competitive', say Indian firms
- Magnifying glass on Sri Lanka on eve of clinical trials bill
- French firms call for action on regulatory shortcomings ahead of presidential election
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
